Evaluation of efficacy of steroid eye dropfor macular disease

Evaluation of efficacy and safety of steroid eye drop(Durezol) for macular edema and neovascular eye disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041180160

Enrollment

130

Registered

2019-03-29

Start date

2008-12-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macula edema, neovascular eye disease macular edema

Interventions

eye drop treatment

treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with mean foveal thickness more than 300 micro meter.

Exclusion criteria

Exclusion criteria: The patients who have history of elevation of intraocular pressure by using steroid drugs.

Design outcomes

Primary

Measure	Time frame
macular thickness, visual acuity	—

Secondary

Measure	Time frame
safety	—

Contacts

Public ContactHidetoshi Yamashita

Faculty of Medicine, Yamagata University

hyama-tky@umin.ac.jp+81-23-628-5374

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026